Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tommy G. Thompson currently holds 23,179 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tommy G. Thompson has been a net seller of UTHR stock. They have purchased $1.7M and sold $12.9M worth of shares.
Tommy G. Thompson's most recent insider trade was on Dec 23, 2025, when they purchased 8,400 shares at $1.67 per share.
Tommy G. Thompson serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 325 insider transactions totaling $14.6M over their tenure at the company.
Tommy G. Thompson holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Tommy G. Thompson has shown a selling trading pattern, with $1.7M in total purchases and $12.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Tommy G. Thompson was on Sep 10, 2025, when they sold $1.8M worth of UTHR shares. This transaction involved 4,560 shares at $403.36 per share.
Tommy G. Thompson currently owns 23,179 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tommy G. Thompson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tommy G. Thompson has 325 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Tommy G. Thompson and 40,000+ other insiders.